What are the major opportunities in the Onychomycosis market? What are the strategies for the Onychomycosis market?

For detailed insights on the major opportunities and strategies in the Onychomycosis market, Read More

How does the Onychomycosis market relate to the overall economy and other similar markets?

For detailed insights on Onychomycosis's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Onychomycosis market growth? SWOT analysis of the Onychomycosis market.

For detailed insights on the key dynamics influencing the Onychomycosis market growth and SWOT analysis of the Onychomycosis industry, Read More

Onychomycosis Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Onychomycosis Market Report 2026

Name: Onychomycosis Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Distal Subungual Onychomycosis (DSO), White Superficial Onychomycosis (WSO), Proximal Subungual Onychomycosis (PSO), Candida Onychomycosis, Other Types), By Treatment (Drug Treatment, Topical Therapy, Other Treatments), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Onychomycosis Market Overview

• Onychomycosis market size has reached to $3.81 billion in 2025

• Expected to grow to $5.09 billion in 2030 at a compound annual growth rate (CAGR) of 6%

• Growth Driver: Rising Diabetic Population Fuels Onychomycosis Market Growth

• Market Trend: Innovative Formulations Transform Onychomycosis Treatment Landscape

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Onychomycosis Market?

Onychomycosis is a fungal infection that affects the nail matrix, bed, or plate, and can impact both toenails and fingernails, leading to discoloration, thickening, and nail crumbling. The goal of treatment is to eradicate the infection, restore the nail's health and appearance, and prevent the fungus from spreading to other nails or skin.

The main types of onychomycoses are distal subungual onychomycosis (DSO), white superficial onychomycosis (WSO), proximal subungual onychomycosis (PSO), candida onychomycosis, and others. Distal subungual onychomycosis (DSO) is a fungal infection affecting the feet’ nails, which can be treated in several ways, such as with oral antifungal drugs, topical antifungal treatments, or sometimes both. The treatment includes drug treatment, topical therapy, and others, which are distributed by hospitals pharmacies, retail pharmacies, and others.

Onychomycosis Market Global Report 2026 Market Report bar graph

What Is The Onychomycosis Market Size and Share 2026?

The onychomycosis market size has grown strongly in recent years. It will grow from $3.81 billion in 2025 to $4.03 billion in 2026 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to high prevalence of onychomycosis, limited availability of advanced antifungal drugs, increasing fungal nail infections due to aging population, growing awareness among dermatologists, early adoption of topical treatments.

What Is The Onychomycosis Market Growth Forecast?

The onychomycosis market size is expected to see strong growth in the next few years. It will grow to $5.09 billion in 2030 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to rising demand for combination therapies, increasing adoption of teledermatology and remote monitoring, growing development of ai-assisted diagnostic solutions, expansion of hospital and retail pharmacy distribution, increasing investment in research for resistant fungal strains. Major trends in the forecast period include rising adoption of personalized antifungal therapies, increasing use of teledermatology for diagnosis and monitoring, growing implementation of ai-based diagnostic tools for nail infections, rising awareness about nail health and hygiene, increasing development of combination drug and topical therapies.

Book your 30 minutes free consultation with our research experts

Global Onychomycosis Market Segmentation

1) By Type: Distal Subungual Onychomycosis (DSO), White Superficial Onychomycosis (WSO), Proximal Subungual Onychomycosis (PSO), Candida Onychomycosis, Other Types

2) By Treatment: Drug Treatment, Topical Therapy, Other Treatments

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels

Subsegments:

1) By Distal Subungual Onychomycosis (DSO): Dermatophyte Infections, Mixed Infections

2) By White Superficial Onychomycosis (WSO): Trichophyton Mentagrophytes Infections

3) By Proximal Subungual Onychomycosis (PSO): Associated with Nail Psoriasis, Fungal Infections In Immunocompromised Patients

4) By Candida Onychomycosis: Candidal Nail Infections, Mixed Fungal-Candida Infections

5) By Other Types: Total Nail Dystrophy, Secondary Onychomycosis

What Is The Driver Of The Onychomycosis Market?

The surge in the diabetic patient population is expected to propel the growth of the onychomycosis market going forward. Diabetes is a chronic disease caused by either insufficient insulin synthesis by the pancreas or ineffective insulin utilization by the body. Onychomycosis is a common foot problem for people with diabetes, which can be managed by preventing and managing complications associated with onychomycosis. Hence, the rising incidence of diabetes boosts the demand for the onychomycosis market. For instance, in June 2024, according to the National Health Service, a UK-based government department, in 2023, the NHS identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This represents a significant increase compared to 3,065,825 in 2022, highlighting a rise of nearly 20%. Therefore, the rising incidence of diabetes is driving the growth of the onychomycosis industry.

Key Players In The Global Onychomycosis Market

Major companies operating in the onychomycosis market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sandoz International GmbH, Bausch Health Companies Inc., Perrigo Company plc, Galderma Laboratories LP, Aurobindo Pharma Limited, Cipla Inc., Dr.Reddy's Laboratories Ltd., Apotex Inc, Lupin Limited, Amneal Pharmaceuticals Inc., Alembic Pharmaceuticals Inc., Kaken Pharmaceutical Co. Ltd., Mayne Pharma Group Limited, Wockhardt Ltd., Jubilant Cadista Pharmaceuticals Inc., Moberg Pharma AB, Medimetriks Pharmaceuticals Inc., Blueberry Therapeutics Ltd., Hallux Inc., NovaBiotics Ltd., Zydus Cadila Healthcare Limited.

Global Onychomycosis Market Trends and Insights

Major companies operating in the onychomycosis market are developing innovative formulations for products to sustain their position in the market. Innovative formulations contribute to the advancement of the onychomycosis market by improving treatment outcomes and addressing specific challenges associated with the condition. For instance, in February 2024, Moberg Pharma AB, a Sweden-based pharmaceutical company, launched MOB-015. It is a proprietary topical formulation of terbinafine designed to deliver effective concentrations directly to the nail and nail bed, minimizing the risk of systemic exposure associated with oral terbinafine. It has received recommendations for national approval in 13 European countries and is marketed in Sweden under the brand name Terclara. The approval is backed by two Phase 3 trials, which showed that MOB-015 achieved superior mycological cure rates (76% compared to up to 42% for comparators) and a significantly higher complete cure rate with no serious adverse reactions reported.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Onychomycosis Market?

In July 2023, Cipher Pharmaceuticals Inc., a Canada-based pharmaceutical company, partnered with Moberg Pharma to MOB-015 for nail fungus treatment. The partnership aims to commercialize MOB-015, a topical nail fungus treatment with superior clinical cure rates, and Moberg Pharma secured EU approval and plans to launch the product across 13 European countries. Moberg Pharma AB is a Sweden-based pharmaceutical company that provides treatment for onychomycosis.

Regional Outlook

North America was the largest region in the onychomycosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Onychomycosis Market?

The onychomycosis market includes revenues earned by services such as combination therapy, oral antifungal medications, itraconazole, ketoconazole, griseofulvin, and terbinafine. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Onychomycosis Market Report 2026?

The onychomycosis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the onychomycosis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Onychomycosis Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$4.03 billion
Revenue Forecast In 2035	$5.09 billion
Growth Rate	CAGR of 5.7% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Treatment, Distribution Channel
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sandoz International GmbH, Bausch Health Companies Inc., Perrigo Company plc, Galderma Laboratories LP, Aurobindo Pharma Limited, Cipla Inc., Dr.Reddy's Laboratories Ltd., Apotex Inc, Lupin Limited, Amneal Pharmaceuticals Inc., Alembic Pharmaceuticals Inc., Kaken Pharmaceutical Co. Ltd., Mayne Pharma Group Limited, Wockhardt Ltd., Jubilant Cadista Pharmaceuticals Inc., Moberg Pharma AB, Medimetriks Pharmaceuticals Inc., Blueberry Therapeutics Ltd., Hallux Inc., NovaBiotics Ltd., Zydus Cadila Healthcare Limited.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Onychomycosis Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Onychomycosis Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Onychomycosis Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Onychomycosis Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Industry 4.0 & Intelligent Manufacturing

4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Digitalization, Cloud, Big Data & Cybersecurity

4.2. Major Trends

4.2.1 Rising Adoption Of Personalized Antifungal Therapies

4.2.2 Increasing Use Of Teledermatology For Diagnosis And Monitoring

4.2.3 Growing Implementation Of Ai-Based Diagnostic Tools For Nail Infections

4.2.4 Rising Awareness About Nail Health And Hygiene

4.2.5 Increasing Development Of Combination Drug And Topical Therapies

5. Onychomycosis Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Dermatology Clinics

5.3 Retail Pharmacies

5.4 Specialty Clinics

5.5 Patients

6. Onychomycosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Onychomycosis Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Onychomycosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Onychomycosis Market Size, Comparisons And Growth Rate Analysis

7.3. Global Onychomycosis Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Onychomycosis Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Onychomycosis Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Onychomycosis Market Segmentation

9.1. Global Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Distal Subungual Onychomycosis (DSO), White Superficial Onychomycosis (WSO), Proximal Subungual Onychomycosis (PSO), Candida Onychomycosis, Other Types

9.2. Global Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Drug Treatment, Topical Therapy, Other Treatments

9.3. Global Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels

9.4. Global Onychomycosis Market, Sub-Segmentation Of Distal Subungual Onychomycosis (DSO), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Dermatophyte Infections, Mixed Infections

9.5. Global Onychomycosis Market, Sub-Segmentation Of White Superficial Onychomycosis (WSO), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Trichophyton Mentagrophytes Infections

9.6. Global Onychomycosis Market, Sub-Segmentation Of Proximal Subungual Onychomycosis (PSO), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Associated with Nail Psoriasis, Fungal Infections In Immunocompromised Patients

9.7. Global Onychomycosis Market, Sub-Segmentation Of Candida Onychomycosis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Candidal Nail Infections, Mixed Fungal-Candida Infections

9.8. Global Onychomycosis Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Total Nail Dystrophy, Secondary Onychomycosis

10. Onychomycosis Market Regional And Country Analysis

10.1. Global Onychomycosis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Onychomycosis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Onychomycosis Market

11.1. Asia-Pacific Onychomycosis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Onychomycosis Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Onychomycosis Market

12.1. China Onychomycosis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Onychomycosis Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Onychomycosis Market

13.1. India Onychomycosis Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Onychomycosis Market

14.1. Japan Onychomycosis Market Overview

14.2. Japan Onychomycosis Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Onychomycosis Market

15.1. Australia Onychomycosis Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Onychomycosis Market

16.1. Indonesia Onychomycosis Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Onychomycosis Market

17.1. South Korea Onychomycosis Market Overview

17.2. South Korea Onychomycosis Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Onychomycosis Market

18.1. Taiwan Onychomycosis Market Overview

18.2. Taiwan Onychomycosis Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Onychomycosis Market

19.1. South East Asia Onychomycosis Market Overview

19.2. South East Asia Onychomycosis Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Onychomycosis Market

20.1. Western Europe Onychomycosis Market Overview

20.2. Western Europe Onychomycosis Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Onychomycosis Market

21.1. UK Onychomycosis Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Onychomycosis Market

22.1. Germany Onychomycosis Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Onychomycosis Market

23.1. France Onychomycosis Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Onychomycosis Market

24.1. Italy Onychomycosis Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Onychomycosis Market

25.1. Spain Onychomycosis Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Onychomycosis Market

26.1. Eastern Europe Onychomycosis Market Overview

26.2. Eastern Europe Onychomycosis Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Onychomycosis Market

27.1. Russia Onychomycosis Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Onychomycosis Market

28.1. North America Onychomycosis Market Overview

28.2. North America Onychomycosis Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Onychomycosis Market

29.1. USA Onychomycosis Market Overview

29.2. USA Onychomycosis Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Onychomycosis Market

30.1. Canada Onychomycosis Market Overview

30.2. Canada Onychomycosis Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Onychomycosis Market

31.1. South America Onychomycosis Market Overview

31.2. South America Onychomycosis Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Onychomycosis Market

32.1. Brazil Onychomycosis Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Onychomycosis Market

33.1. Middle East Onychomycosis Market Overview

33.2. Middle East Onychomycosis Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Onychomycosis Market

34.1. Africa Onychomycosis Market Overview

34.2. Africa Onychomycosis Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Onychomycosis Market Regulatory and Investment Landscape

36. Onychomycosis Market Competitive Landscape And Company Profiles

36.1. Onychomycosis Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Onychomycosis Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Onychomycosis Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

37. Onychomycosis Market Other Major And Innovative Companies

Sandoz International GmbH, Bausch Health Companies Inc., Perrigo Company plc, Galderma Laboratories LP, Aurobindo Pharma Limited, Cipla Inc., Dr.Reddy's Laboratories Ltd., Apotex Inc, Lupin Limited, Amneal Pharmaceuticals Inc., Alembic Pharmaceuticals Inc., Kaken Pharmaceutical Co. Ltd., Mayne Pharma Group Limited, Wockhardt Ltd., Jubilant Cadista Pharmaceuticals Inc.

38. Global Onychomycosis Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Onychomycosis Market

40. Onychomycosis Market High Potential Countries, Segments and Strategies

40.1 Onychomycosis Market In 2030 - Countries Offering Most New Opportunities

40.2 Onychomycosis Market In 2030 - Segments Offering Most New Opportunities

40.3 Onychomycosis Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Onychomycosis Market, Overview Of Key Products - Product Examples

Table 2: Global Onychomycosis Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Onychomycosis Market, Supply Chain Analysis

Table 4: Global Onychomycosis Market, Major Raw Material Providers

Table 5: Global Onychomycosis Market, Major Resource Providers

Table 6: Global Onychomycosis Market, Major Manufacturers (Suppliers)

Table 7: Global Onychomycosis Market, Major Distributors And Channel Partners

Table 8: Global Onychomycosis Market, Key Technologies & Future Trends

Table 9: Global Onychomycosis Market, Major Trends

Table 10: Global Onychomycosis Market, Major End Users

Table 11: Global Onychomycosis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Onychomycosis Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Onychomycosis Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Onychomycosis Market - TAM, US$ Billion, 2025

Table 15: Global Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Onychomycosis Market, Sub-Segmentation Of Distal Subungual Onychomycosis (DSO), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Onychomycosis Market, Sub-Segmentation Of White Superficial Onychomycosis (WSO), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Onychomycosis Market, Sub-Segmentation Of Proximal Subungual Onychomycosis (PSO), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Onychomycosis Market, Sub-Segmentation Of Candida Onychomycosis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Onychomycosis Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Onychomycosis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Onychomycosis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Global Onychomycosis Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 98: Global Onychomycosis Market - Company Scoring Matrix

Table 99: Pfizer Inc. Financial Performance

Table 100: Johnson & Johnson Services Inc. Financial Performance

Table 101: Merck & Co. Inc. Financial Performance

Table 102: Bayer AG Financial Performance

Table 103: Novartis AG Financial Performance

Table 104: Global Onychomycosis Market, Competitive Benchmarking (In USD Billions)

Table 105: Global Onychomycosis Market, Competitive Dashboard

Table 106: Global Onychomycosis Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 107: Global, Onychomycosis Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 108: Global, Onychomycosis Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030

Table 109: Global, Onychomycosis Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

Figure 1: Global Onychomycosis Market, Overview Of Key Products - Product Examples

Figure 2: Global Onychomycosis Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Onychomycosis Market, Supply Chain Analysis

Figure 4: Global Onychomycosis Market, Major Raw Material Providers

Figure 5: Global Onychomycosis Market, Major Resource Providers

Figure 6: Global Onychomycosis Market, Major Manufacturers (Suppliers)

Figure 7: Global Onychomycosis Market, Major Distributors And Channel Partners

Figure 8: Global Onychomycosis Market, Key Technologies & Future Trends

Figure 9: Global Onychomycosis Market, Major Trends

Figure 10: Global Onychomycosis Market, Major End Users

Figure 11: Global Onychomycosis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Onychomycosis Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Onychomycosis Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Onychomycosis Market - TAM, US$ Billion, 2025

Figure 15: Global Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Onychomycosis Market, Sub-Segmentation Of Distal Subungual Onychomycosis (DSO), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Onychomycosis Market, Sub-Segmentation Of White Superficial Onychomycosis (WSO), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Onychomycosis Market, Sub-Segmentation Of Proximal Subungual Onychomycosis (PSO), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Onychomycosis Market, Sub-Segmentation Of Candida Onychomycosis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Onychomycosis Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Onychomycosis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Onychomycosis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Global Onychomycosis Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 98: Global Onychomycosis Market - Company Scoring Matrix

Figure 99: Pfizer Inc. Financial Performance

Figure 100: Johnson & Johnson Services Inc. Financial Performance

Figure 101: Merck & Co. Inc. Financial Performance

Figure 102: Bayer AG Financial Performance

Figure 103: Novartis AG Financial Performance

Figure 104: Global Onychomycosis Market, Competitive Benchmarking (In USD Billions)

Figure 105: Global Onychomycosis Market, Competitive Dashboard

Figure 106: Global Onychomycosis Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 107: Global, Onychomycosis Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 108: Global, Onychomycosis Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030

Figure 109: Global, Onychomycosis Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Next-Gen Primary Health Care Service : Market Forecast, Transformation, and Long-Term Trajectories

Progressive Ataxia And Weakness Disorders Growth Trajectory: Key Forecasts and Strategic Insights

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Flood Barrier Market Report 2026 - Global Outlook – By Type (Flip-Up Flood Barriers, Removable Flood Barriers, Self-Closing Flood Barriers, Drop-Down Flood Barriers, Other Types), By Material (Aluminum, Steel, Concrete, ...

Prenatal And Newborn Genetic Testing Market Report 2026 - Global Outlook – By Product Type (Consumables, Instruments), By Screening (Non-Invasive Prenatal Testing, Chronic Villus Sampling, Amniocentesis, Maternal Serum S...

Automotive Data Cables Market Report 2026 - Global Outlook – By Cable (Controller Area Network (CAN), Low Voltage Differential Signaling (LVDS) Or High Speed Data (HSD), FlexRay, Ethernet, Controller Area Network Flexibl...

Hernia Mesh Devices Market Report 2026 - Global Outlook – By Mesh Type (Biologic Mesh, Synthetic Mesh), By Procedure (Open Surgeries, Laparoscopic Surgeries, Robotic Surgeries), By Hernia Type (Incisional Hernia, Umbilic...

Appendiceal Cancer Treatment Market Report 2026 - Global Outlook – By Type (Colonic-Type Adenocarcinoma, Mucinous Adenocarcinoma Of Appendix, Goblet Cell Adenocarcinoma, Neuroendocrine Carcinoma, Other Types), By Treatme...

Cell Culture Media Storage Containers Market Report 2026 - Global Outlook – By Product (Storage Bag, Storage Bottle, Storage Bin And Drum), By Application (Biopharmaceutical Production, Tissue Engineering, Diagnostic, Re...

Antifungals Market Report 2026 - Global Outlook – By Drug Type (Echinocandins, Azoles, Polyenes, Allylamines ), By Route of Administration (Oral, Parenteral, Topical ), By End users (Hospitals & Clinics, Dermatology clin...

Frequently Asked Questions

How big is the Onychomycosis Market?

The Onychomycosis market was valued at $3.81 billion in 2025, increased to $4.03 billion in 2026, and is projected to reach $5.09 billion by 2030.

What is the Onychomycosis market growth?

The global Onychomycosis market is expected to grow at a CAGR of 6.0% from 2026 to 2035 to reach $5.09 billion by 2035.

Who are the key players in Onychomycosis market?

Some Key Players in the Onychomycosis market Include, Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sandoz International GmbH, Bausch Health Companies Inc., Perrigo Company plc, Galderma Laboratories LP, Aurobi

Major trend in this market includes: Innovative Formulations Transform Onychomycosis Treatment Landscape. For further insights on this market. request a sample here

North America was the largest region in the onychomycosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the onychomycosis market report are Asia-Pacific, South East A

Book your 30 minutes free consultation with our research experts

Contact Us